Triple-Negative Breast Cancer: What New Clinical Trials Are Uncovering
Triple-Negative Breast Cancer: What New Clinical Trials are UncoveringDiane Barker lives in Sydney with her husband Mike, their daughter Eva, and their dog Boston. In December 2020, at just 44 years o...
6 Des 202237min
Practice-Changing Clinical Trials: Insights from a Breast Cancer Trials Founder
Developing Breakthrough Treatments for Invasive Lobular CarcinomaSince 1978, Breast Cancer Trials has conducted a number of clinical trials which have changed the way we treat breast cancer, save live...
24 Nov 202213min
Developing Breakthrough Treatments for Invasive Lobular Carcinoma
Developing Breakthrough Treatments for Invasive Lobular CarcinomaInvasive Lobular Carcinoma (ILC) is the second most common subtype of breast cancer, with 2,400 new cases each year in Australia. Patie...
25 Okt 20224min
How to Ease the Fear of Breast Cancer Recurrence
How to Ease the Fear of Breast Cancer RecurrenceApproximately 70% of women experience moderate to high levels of fear of cancer recurrence (FCR) and up to 15% experience severe, disabling FCR characte...
10 Okt 20226min
Endocrine Therapy: Are We Overtreating Breast Cancer?
Endocrine Therapy: Are We Overtreating Breast Cancer?Endocrine Therapy, also known as hormone therapy, is a treatment that tries to block or reduce circulating estrogens, which are what drive the majo...
20 Sep 20226min
HER2+ Metastatic Breast Cancer: Are We Getting Closer to a Cure?
HER2+ Metastatic Breast Cancer: Are We Getting Closer to a Cure?Dr David Okonji is a Medical Oncologist at Wellington Hospital in New Zealand, who is researching metastatic breast cancer. He's asking ...
20 Sep 20228min
Supporting a Loved One Through Breast Cancer: What Really Helps?
Supporting a Loved One Through Breast Cancer: What Really Helps?Associate Professor Lesley Stafford is a clinical psychologist in psycho-oncology and women's health, with a specific interest in women ...
15 Sep 202215min
CDK4/6 Inhibitors: Are We Using Them to Their Full Potential?
CDK4/6 Inhibitors: Are We Using Them to Their Full Potential?Dr Shom Goel is a clinician-scientist at the University of Melbourne and Peter MacCallum Cancer Centre, with a strong interest in Translati...
15 Sep 20225min
